Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Neuromuscular Disorders : NMD
|
September 11, 2002
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?
Giuliana Ferrari, Fulvio Mavilio
Blood Cells, Molecules & Diseases
|
January 17, 2018
Gene therapy and gene editing strategies for hemoglobinopathies
Maria Rosa Lidonnici, Giuliana Ferrari
Hematology/Oncology Clinics of North America
|
September 13, 2017
Gene Therapy Approaches to Hemoglobinopathies
Giuliana Ferrari, Marina Cavazzana, Fulvio Mavilio
Human Gene Therapy
|
September 7, 2023
Gene Therapy for Hemoglobinopathies
Maria Rosa Lidonnici, Samantha Scaramuzza, Giuliana Ferrari
Nature Reviews. Genetics
|
December 11, 2020
Gene therapy using haematopoietic stem and progenitor cells
Giuliana Ferrari, Adrian J Thrasher, Alessandro Aiuti
Cell Reports. Medicine
|
November 18, 2025
Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche
Annamaria Aprile, Maria Rosa Lidonnici, Giuliana Ferrari
Pharmaceuticals (Basel, Switzerland)
|
May 28, 2022
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
Annamaria Aprile, Silvia Sighinolfi, Laura Raggi, et al.
Stem Cells (Dayton, Ohio)
|
March 25, 2010
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway
Alexandros Xynos, Paola Corbella, Nathalie Belmonte, et al.
The Journal of Biological Chemistry
|
January 1, 2004
Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression
Anna Testa, Francesco Lotti, Linda Cairns, et al.
Journal of Virology
|
March 22, 2002
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement
Francesco Lotti, Emilio Menguzzato, Claudia Rossi, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Neuromuscular Disorders : NMD
|
September 11, 2002
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?
Giuliana Ferrari, Fulvio Mavilio
Blood Cells, Molecules & Diseases
|
January 17, 2018
Gene therapy and gene editing strategies for hemoglobinopathies
Maria Rosa Lidonnici, Giuliana Ferrari
Hematology/Oncology Clinics of North America
|
September 13, 2017
Gene Therapy Approaches to Hemoglobinopathies
Giuliana Ferrari, Marina Cavazzana, Fulvio Mavilio
Human Gene Therapy
|
September 7, 2023
Gene Therapy for Hemoglobinopathies
Maria Rosa Lidonnici, Samantha Scaramuzza, Giuliana Ferrari
Nature Reviews. Genetics
|
December 11, 2020
Gene therapy using haematopoietic stem and progenitor cells
Giuliana Ferrari, Adrian J Thrasher, Alessandro Aiuti
Cell Reports. Medicine
|
November 18, 2025
Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche
Annamaria Aprile, Maria Rosa Lidonnici, Giuliana Ferrari
Pharmaceuticals (Basel, Switzerland)
|
May 28, 2022
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
Annamaria Aprile, Silvia Sighinolfi, Laura Raggi, et al.
Stem Cells (Dayton, Ohio)
|
March 25, 2010
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway
Alexandros Xynos, Paola Corbella, Nathalie Belmonte, et al.
The Journal of Biological Chemistry
|
January 1, 2004
Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression
Anna Testa, Francesco Lotti, Linda Cairns, et al.
Journal of Virology
|
March 22, 2002
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement
Francesco Lotti, Emilio Menguzzato, Claudia Rossi, et al.
Page
of 6